title: Therapeutic Developments for Tics and Myoclonus.
abstract: Tics and myoclonus are phenomenologically similar given that both are jerk-like movements, but, in contrast to myoclonus, tics are often preceded by premonitory sensations and are typically associated with a variety of behavioral comorbidities, including attention deficit and obsessive-compulsive disorder. There are many other clinical features that help differentiate these two hyperkinetic disorders. Whereas behavioral and antidopaminergic therapies are most effective in the management of tics, clonazepam, other anticonvulsants, and serotonergic drugs are often used to control myoclonic movements. Botulinum toxin may also be helpful in focal tics and in segmental forms of myoclonus. DBS plays an increasingly important role in the treatment of these disorders, particularly when they are generalized and are disabling despite optimal medical therapy.
authors: Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, USA.
authors: Joseph
authors: J
authors: Jankovic
mesh_terms: D001905:Botulinum Toxins / Q000627:therapeutic use*; D046690:Deep Brain Stimulation / Q000379:methods*; D006801:Humans; D009207:Myoclonus / Q000628:therapy*; D009498:Neurotoxins / Q000627:therapeutic use*; D020323:Tics / Q000628:therapy*
chemical_list: D009498:Neurotoxins; D001905:Botulinum Toxins
keywords: Tourette syndrome; myoclonus; tics; treatment